{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:17:30Z","timestamp":1784265450343,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Natural Science Foundation of Hubei Province","award":["2023AFB711"],"award-info":[{"award-number":["2023AFB711"]}]},{"name":"Cross-Innovation Talent Program of Renmin Hospital of Wuhan University","award":["JCRCFZ-2022-021"],"award-info":[{"award-number":["JCRCFZ-2022-021"]}]},{"name":"the Natural Science Foundation of Guangxi Zhuang Autonomous Region","award":["2024GXNSFAA999020"],"award-info":[{"award-number":["2024GXNSFAA999020"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32370777"],"award-info":[{"award-number":["32370777"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-025-02514-3","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T14:24:35Z","timestamp":1763735075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["USP13 promotes colorectal cancer progression by deubiquitinating and stabilizing HIF-1\u03b1"],"prefix":"10.1186","volume":"23","author":[{"given":"Bo","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai-Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Bo","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Lei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2514_CR1","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233\u201354.","journal-title":"CA Cancer J Clin"},{"key":"2514_CR2","first-page":"167","volume":"25","author":"A Suvac","year":"2025","unstructured":"Suvac A, Ashton J, Bristow RG. Tumour hypoxia in driving genomic instability and tumour evolution. Nat Rev Cancer. 2025;25:167\u201388.","journal-title":"Nat Rev Cancer"},{"key":"2514_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02229-6","volume":"41","author":"S Dong","year":"2022","unstructured":"Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, et al. ROS\/PI3K\/Akt and Wnt\/\u03b2-catenin signalings activate HIF-1\u03b1-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. J Exp Clin Cancer Res. 2022;41:15.","journal-title":"J Exp Clin Cancer Res"},{"key":"2514_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06958-2","volume":"15","author":"X Zhong","year":"2024","unstructured":"Zhong X, Wang Y, He X, He X, Hu Z, Huang H, et al. HIF1A-AS2 promotes the metabolic reprogramming and progression of colorectal cancer via miR-141-3p\/FOXC1 axis. Cell Death Dis. 2024;15:645.","journal-title":"Cell Death Dis"},{"key":"2514_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103286","volume":"75","author":"Z Lin","year":"2024","unstructured":"Lin Z, Yang S, Qiu Q, Cui G, Zhang Y, Yao M, et al. Hypoxia-induced cysteine metabolism reprogramming is crucial for the tumorigenesis of colorectal cancer. Redox Biol. 2024;75:103286.","journal-title":"Redox Biol"},{"key":"2514_CR6","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A. 1995;92:5510\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2514_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337\u201340.","journal-title":"Science"},{"key":"2514_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271\u20135.","journal-title":"Nature"},{"key":"2514_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian Y-M, Wilson MI, Gielbert J, Gaskell SJ, et al. Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2 -regulated prolyl hydroxylation. Science. 2001;292:468\u201372.","journal-title":"Science"},{"key":"2514_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 2001;292:464\u20138.","journal-title":"Science"},{"key":"2514_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159839","volume":"132","author":"EE Wicks","year":"2022","unstructured":"Wicks EE, Semenza GL. Hypoxia-inducible factors: cancer progression and clinical translation. J Clin Invest. 2022;132:e159839.","journal-title":"J Clin Invest"},{"key":"2514_CR12","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1128\/MCB.00015-07","volume":"27","author":"D Fl\u00fcgel","year":"2007","unstructured":"Fl\u00fcgel D, G\u00f6rlach A, Michiels C, Kietzmann T. Glycogen synthase kinase 3 phosphorylates Hypoxia-Inducible factor 1 \u03b1 and mediates its destabilization in a VHL-independent manner. Mol Cell Biol. 2007;27:3253\u201365.","journal-title":"Mol Cell Biol"},{"key":"2514_CR13","doi-asserted-by":"publisher","first-page":"E3325","DOI":"10.1073\/pnas.1412840111","volume":"111","author":"ME Hubbi","year":"2014","unstructured":"Hubbi ME, Gilkes DM, Hu H, Kshitiz null, Ahmed I, Semenza GL. Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1\u03b1 to promote cell-cycle progression. Proc Natl Acad Sci U S A. 2014;111:E3325\u20133334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2514_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0092-8674(02)01085-1","volume":"111","author":"JW Jeong","year":"2002","unstructured":"Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH, et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002;111:709\u201320.","journal-title":"Cell"},{"issue":"6","key":"2514_CR15","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","volume":"38","author":"J-H Lim","year":"2010","unstructured":"Lim J-H, Lee Y-M, Chun Y-S, Chen J, Kim J-E, Park J-W. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1\u03b1. Mol Cell. 2010;38(6):864\u201378.","journal-title":"Mol Cell"},{"key":"2514_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10347","volume":"7","author":"Y Kim","year":"2016","unstructured":"Kim Y, Nam HJ, Lee J, Park DY, Kim C, Yu YS, et al. Methylation-dependent regulation of HIF-1\u03b1 stability restricts retinal and tumour angiogenesis. Nat Commun. 2016;7:10347.","journal-title":"Nat Commun"},{"key":"2514_CR17","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/onc.2017.158","volume":"36","author":"J-Y Lee","year":"2017","unstructured":"Lee J-Y, Park J-H, Choi H-J, Won H-Y, Joo H-S, Shin D-H, et al. LSD1 demethylates HIF1\u03b1 to inhibit hydroxylation and ubiquitin-mediated degradation in tumor angiogenesis. Oncogene. 2017;36:5512\u201321.","journal-title":"Oncogene"},{"key":"2514_CR18","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1093\/emboj\/19.16.4298","volume":"19","author":"K Tanimoto","year":"2000","unstructured":"Tanimoto K, Makino Y, Pereira T, Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 2000;19:4298\u2013309.","journal-title":"EMBO J"},{"key":"2514_CR19","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1002\/jcb.23321","volume":"112","author":"JM Cassavaugh","year":"2011","unstructured":"Cassavaugh JM, Hale SA, Wellman TL, Howe AK, Wong C, Lounsbury KM. Negative regulation of HIF-1\u03b1 by an FBW7-mediated degradation pathway during hypoxia. J Cell Biochem. 2011;112:3882\u201390.","journal-title":"J Cell Biochem"},{"key":"2514_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01947-w","volume":"8","author":"J Liu","year":"2017","unstructured":"Liu J, Zhang C, Zhao Y, Yue X, Wu H, Huang S, et al. Parkin targets HIF-1\u03b1 for ubiquitination and degradation to inhibit breast tumor progression. Nat Commun. 2017;8:1823.","journal-title":"Nat Commun"},{"key":"2514_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112870","volume":"42","author":"S Liu","year":"2023","unstructured":"Liu S, Guo R, Xu H, Yang J, Luo H, Yeung S-CJ, et al. 14-3-3\u03c3-NEDD4L axis promotes ubiquitination and degradation of HIF-1\u03b1 in colorectal cancer. Cell Rep. 2023;42:112870.","journal-title":"Cell Rep"},{"key":"2514_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ccr.2013.12.008","volume":"25","author":"J Li","year":"2014","unstructured":"Li J, Xu Y, Long X-D, Wang W, Jiao H-K, Mei Z, et al. Cbx4 governs HIF-1\u03b1 to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell. 2014;25:118\u201331.","journal-title":"Cancer Cell"},{"key":"2514_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-025-02366-x","volume":"23","author":"C Li","year":"2025","unstructured":"Li C, Fu C, Zhou W, Li H, Liu Z, Wu G, et al. Lactylation modification of HIF-1\u03b1 enhances its stability by blocking VHL recognition. Cell Commun Signal. 2025;23:364.","journal-title":"Cell Commun Signal"},{"key":"2514_CR24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2500562122","volume":"122","author":"Y Zou","year":"2025","unstructured":"Zou Y, Wang Z, Jiang Q, Kong X, Ma X, Liang Z, et al. Ufmylation: a supervisor of the HIF1\u03b1 pathway and a potential therapeutic target for anti-PD-1 combination therapy in hypoxic tumors. Proc Natl Acad Sci U S A. 2025;122:e2500562122.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2514_CR25","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","volume":"23","author":"G Dewson","year":"2023","unstructured":"Dewson G, Eichhorn PJA, Komander D. Deubiquitinases in cancer. Nat Rev Cancer. 2023;23:842\u201362.","journal-title":"Nat Rev Cancer"},{"key":"2514_CR26","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague MJ, Urb\u00e9 S, Komander D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol. 2019;20:338\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2514_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/embr.201337688","volume":"15","author":"A Troilo","year":"2014","unstructured":"Troilo A, Alexander I, Muehl S, Jaramillo D, Knobeloch K, Krek W. HIF1\u03b1 deubiquitination by USP8 is essential for ciliogenesis in normoxia. EMBO Rep. 2014;15:77\u201385.","journal-title":"EMBO Rep"},{"key":"2514_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01963-5","volume":"9","author":"Q Shan","year":"2024","unstructured":"Shan Q, Yin L, Zhan Q, Yu J, Pan S, Zhuo J, et al. The p-MYH9\/USP22\/HIF-1\u03b1 axis promotes lenvatinib resistance and cancer stemness in hepatocellular carcinoma. Sig Transduct Target Ther. 2024;9:249.","journal-title":"Sig Transduct Target Ther"},{"key":"2514_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29684-9","volume":"13","author":"JK Nelson","year":"2022","unstructured":"Nelson JK, Thin MZ, Evan T, Howell S, Wu M, Almeida B, et al. USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer. Nat Commun. 2022;13:2070.","journal-title":"Nat Commun"},{"key":"2514_CR30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2217840120","volume":"120","author":"A Bononi","year":"2023","unstructured":"Bononi A, Wang Q, Zolondick AA, Bai F, Steele-Tanji M, Suarez JS, et al. BAP1 is a novel regulator of HIF-1\u03b1. Proc Natl Acad Sci USA. 2023;120:e2217840120.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2514_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7153","volume":"6","author":"Y Goto","year":"2015","unstructured":"Goto Y, Zeng L, Yeom CJ, Zhu Y, Morinibu A, Shinomiya K, et al. UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1\u03b1. Nat Commun. 2015;6(1):6153.","journal-title":"Nat Commun"},{"key":"2514_CR32","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1038\/ncb2874","volume":"15","author":"J Zhang","year":"2013","unstructured":"Zhang J, Zhang P, Wei Y, Piao H, Wang W, Maddika S, et al. Deubiquitylation and stabilization of PTEN by USP13. Nat Cell Biol. 2013;15:1486\u201394.","journal-title":"Nat Cell Biol"},{"key":"2514_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1421","volume":"2","author":"X Zhao","year":"2011","unstructured":"Zhao X, Fiske B, Kawakami A, Li J, Fisher DE. Regulation of MITF stability by the USP13 deubiquitinase. Nat Commun. 2011;2:414.","journal-title":"Nat Commun"},{"key":"2514_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15534","volume":"8","author":"H Sun","year":"2017","unstructured":"Sun H, Zhang Q, Jing Y-Y, Zhang M, Wang H-Y, Cai Z, et al. Usp13 negatively regulates antiviral responses by deubiquitinating STING. Nat Commun. 2017;8:15534.","journal-title":"Nat Commun"},{"key":"2514_CR35","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1016\/j.celrep.2020.01.088","volume":"30","author":"W Xie","year":"2020","unstructured":"Xie W, Jin S, Wu Y, Xian H, Tian S, Liu D-A, et al. Auto-ubiquitination of NEDD4-1 recruits USP13 to facilitate autophagy through deubiquitinating VPS34. Cell Rep. 2020;30:2807\u2013e28194.","journal-title":"Cell Rep"},{"key":"2514_CR36","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1038\/s41388-023-02739-x","volume":"42","author":"C Ma","year":"2023","unstructured":"Ma C, Wang D, Tian Z, Gao W, Zang Y, Qian L, et al. USP13 deubiquitinates and stabilizes Cyclin D1 to promote gastric cancer cell cycle progression and cell proliferation. Oncogene. 2023;42:2249\u201362.","journal-title":"Oncogene"},{"key":"2514_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113511","volume":"42","author":"Y Guo","year":"2023","unstructured":"Guo Y, Tian J, Guo Y, Wang C, Chen C, Cai S, et al. Oncogenic KRAS effector USP13 promotes metastasis in non-small cell lung cancer through deubiquitinating \u03b2-catenin. Cell Rep. 2023;42:113511.","journal-title":"Cell Rep"},{"key":"2514_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adx3827","volume":"11","author":"Y-T Li","year":"2025","unstructured":"Li Y-T, Li K-Y, Tao S-S, Wang T, Lu Y, Chen H, et al. USP13 stabilizes NLRP3 to facilitate inflammasome activation by preventing TRIM31-mediated NLRP3 ubiquitination and degradation. Sci Adv. 2025;11:eadx3827.","journal-title":"Sci Adv"},{"key":"2514_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61028-1","volume":"16","author":"J Han","year":"2025","unstructured":"Han J, Lin L, Fang Z, Xu D, Wang L, Ye B, et al. Cardiomyocyte-derived USP13 protects hearts from hypertrophy via deubiquitinating and stabilizing STAT1 in male mice. Nat Commun. 2025;16:5927.","journal-title":"Nat Commun"},{"key":"2514_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67289-8","volume":"10","author":"G Carpentier","year":"2020","unstructured":"Carpentier G, Berndt S, Ferratge S, Rasband W, Cuendet M, Uzan G, et al. Angiogenesis analyzer for ImageJ - a comparative morphometric analysis of endothelial tube formation assay and fibrin bead assay. Sci Rep. 2020;10:11568.","journal-title":"Sci Rep"},{"key":"2514_CR41","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz S, Popp V, Kindermann M, Gerlach K, Weigmann B, Fichtner-Feigl S, et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat Protoc. 2017;12:1295\u2013309.","journal-title":"Nat Protoc"},{"key":"2514_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2023.10.006","volume":"80","author":"L Zhang","year":"2024","unstructured":"Zhang L, Xu J, Zhou S, Yao F, Zhang R, You W, et al. Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. J Hepatol. 2024;80:82\u201398.","journal-title":"J Hepatol"},{"key":"2514_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05397-1","volume":"13","author":"Y-H Chen","year":"2022","unstructured":"Chen Y-H, Xu N-Z, Hong C, Li W-Q, Zhang Y-Q, Yu X-Y, et al. Myo1b promotes tumor progression and angiogenesis by inhibiting autophagic degradation of HIF-1\u03b1 in colorectal cancer. Cell Death Dis. 2022;13:939.","journal-title":"Cell Death Dis"},{"key":"2514_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216940","volume":"593","author":"C Huang","year":"2024","unstructured":"Huang C, Tan H, Wang J, Huang L, Liu H, Shi Y, et al. \u03b2-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1\u03b1-mediated angiogenesis. Cancer Lett. 2024;593:216940.","journal-title":"Cancer Lett"},{"key":"2514_CR45","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.ccell.2025.02.015","volume":"43","author":"Z Yang","year":"2025","unstructured":"Yang Z, Su W, Wei X, Pan Y, Xing M, Niu L, et al. Hypoxia inducible factor-1\u03b1 drives cancer resistance to Cuproptosis. Cancer Cell. 2025;43:937\u201354.","journal-title":"Cancer Cell"},{"key":"2514_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.yexcr.2017.03.041","volume":"356","author":"GL Semenza","year":"2017","unstructured":"Semenza GL. A compendium of proteins that interact with HIF-1\u03b1. Exp Cell Res. 2017;356:128\u201335.","journal-title":"Exp Cell Res"},{"key":"2514_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-017-0533-1","volume":"36","author":"M Wang","year":"2017","unstructured":"Wang M, Zhao X, Zhu D, Liu T, Liang X, Liu F, et al. HIF-1\u03b1 promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res. 2017;36:60.","journal-title":"J Exp Clin Cancer Res"},{"key":"2514_CR48","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","volume":"147","author":"J Liu","year":"2011","unstructured":"Liu J, Xia H, Kim M, Xu L, Li Y, Zhang L, et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell. 2011;147:223\u201334.","journal-title":"Cell"},{"key":"2514_CR49","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1111\/jcmm.15093","volume":"24","author":"J Guo","year":"2020","unstructured":"Guo J, Zhang J, Liang L, Liu N, Qi M, Zhao S, et al. Potent USP10\/13 antagonist spautin-1 suppresses melanoma growth via ROS-mediated DNA damage and exhibits synergy with cisplatin. J Cell Mol Med. 2020;24:4324\u201340.","journal-title":"J Cell Mol Med"},{"key":"2514_CR50","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1002\/ijc.33404","volume":"148","author":"P Giron","year":"2021","unstructured":"Giron P, Eggermont C, Noeparast A, Vandenplas H, Teugels E, Forsyth R, et al. Targeting USP13-mediated drug tolerance increases the efficacy of EGFR inhibition of mutant EGFR in non-small cell lung cancer. Int J Cancer. 2021;148:2579\u201393.","journal-title":"Int J Cancer"},{"key":"2514_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02693-9","volume":"9","author":"S Zhang","year":"2018","unstructured":"Zhang S, Zhang M, Jing Y, Yin X, Ma P, Zhang Z, et al. Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitors. Nat Commun. 2018;9:215.","journal-title":"Nat Commun"},{"key":"2514_CR52","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41418-022-01107-8","volume":"30","author":"Z Gao","year":"2023","unstructured":"Gao Z, Li C, Sun H, Bian Y, Cui Z, Wang N, et al. N6-methyladenosine-modified USP13 induces pro-survival autophagy and Imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors. Cell Death Differ. 2023;30:544\u201359.","journal-title":"Cell Death Differ"},{"key":"2514_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.140608","volume":"304","author":"L Yi","year":"2025","unstructured":"Yi L, Shahatiaili A, Zhang L, He H, Chen L, Zhang Z, et al. USP13: a therapeutic target for combating tumorigenesis and antitumor therapy resistance. Int J Biol Macromol. 2025;304:140608.","journal-title":"Int J Biol Macromol"},{"key":"2514_CR54","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191779","volume":"217","author":"Q Zhou","year":"2020","unstructured":"Zhou Q, Lin M, Feng X, Ma F, Zhu Y, Liu X, et al. Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. J Exp Med. 2020;217:e20191779.","journal-title":"J Exp Med"},{"key":"2514_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51882-w","volume":"15","author":"R Chen","year":"2024","unstructured":"Chen R, Lin Z, Shen S, Zhu C, Yan K, Suo C, et al. Citrullination modulation stabilizes HIF-1\u03b1 to promote tumour progression. Nat Commun. 2024;15:7654.","journal-title":"Nat Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02514-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02514-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:03:49Z","timestamp":1763741029000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02514-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2514"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02514-3","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocols for patients were approved by the Institute Research Medical Ethics Committee of the Affiliated Second Hospital, University of South China (approval no.2024085). All animal experiments received approval from the Institutional Animal Care and Use Committee of Wuhan University (approval no.15060\u00a0A).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"502"}}